Community pharmacy services for antidepressant users

Author:

Gardner D M1,Murphy A L1,Woodman A K1,Connelly S1

Affiliation:

1. College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada

Abstract

Abstract Objective To evaluate the communication and barriers to communication between community-based pharmacists and antidepressant users. Method A survey package designed to evaluate the communication between pharmacists and antidepressant users was distributed to 50 community pharmacies. Each package included one pharmacist survey and 10 sealed antidepressant user surveys to be distributed by the pharmacy staff. The survey addressed the components of communication, level of satisfaction and barriers to effective communication. Setting Urban and rural community pharmacies in the Canadian Maritime provinces of Nova Scotia and New Brunswick. Key findings Overall, pharmacists rated the value of their communication more highly than did antidepressant users, although the difference was not statistically significant. When beginning treatment, between one-half and two-thirds of antidepressant users recalled pharmacists inquiring about past use of the antidepressant and discussing information provided by the physician, time to onset of benefits and potential side effects. The purpose of the antidepressant, target symptoms, usual duration of therapy and risk of relapse with premature discontinuation were addressed less often according to antidepressant users, and monitoring of compliance was not a common activity. Antidepressant users estimated that initial communication with the pharmacist generally lasted less than five minutes, and often less than two minutes. However, pharmacists appeared to resolve misconceptions and concerns about antidepressant use efficiently. According to pharmacists, the major barrier to effective communication was a lack of privacy. Conclusion Although compliance with antidepressants is low and treatment outcomes are sub-optimal, pharmacists are not using their opportunities to minimise this problem through effective communication and follow-up. Pharmacists, pharmacy administrators and regulators need to re-assess their contribution to this problem and how they can lead to its resolution in the patient's best interest.

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmaceutical Science,Pharmacy

Reference24 articles.

1. Undertreatment of major depression;Keller;Psychopharmacol Bull,1988

2. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community;Tylee;Int Clin Psychopharmacol,1999

3. Differences between prescription and consumption of antidepressants and anxiolytics;Lecrubier;Int Clin Psychopharmacol,1998

4. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society);Lepine;Int Clin Psychopharmacol,1997

5. Epidemiology of affective disorders: a review;Bland;Can J Psychiatry,1997

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3